XtalPi Inc. and China Pharmaceutical University Launch Joint AI Research Center in China
Sino-US artificial intelligence (AI) firm XtalPi Inc. has joined forces with China Pharmaceutical University (CPU)...
Deals
Hasten Biopharm Acquires Commercial Rights to Rocephin in China from Roche
China-based Hasten Biopharmaceutical Co., Ltd has announced the acquisition of the commercial rights in China...
VivaVision Biotech Secures Over RMB 100 Million in Series D2 Financing for Ophthalmology Pipeline Expansion
China’s VivaVision Biotech Inc. has announced the successful completion of its Series D2 financing round,...
Kangrui Health Partners with West China Second University Hospital for Pediatric Care Innovation
Kangrui Health, a leading data and intelligence application company based in Beijing, has entered into...
Medisan Pharmaceutical Secures PPAR Agonist Technology from China Pharmaceutical University
Harbin Medisan Pharmaceutical Co., Ltd (SHE: 002900) has announced a significant patent and technology transfer...
NeuExcell Therapeutics Secures Over $14.5 Million in Pre-Series A+ Funding for Neurological Treatments
NeuExcell Therapeutics, a Sino-US biotech company specializing in treatments for neurological damage and degenerative diseases,...
Cellular Biomedicine Group Inc. and Janssen Biotech, Inc. Announce Global Collaboration for CAR-T Therapies
China-based cell therapy specialist Cellular Biomedicine Group Inc. (CBMG), emerging from a merger deal in...
Johnson & Johnson’s Kenvue IPO Raises USD 3.8 Billion, Marking Year’s Largest US IPO
US healthcare giant Johnson & Johnson (J&J, NYSE: JNJ) has announced the initial public offering...
Reforgene Medicine Secures Pre-Series B Funding to Advance Thalassemia Gene Therapy
Reforgene Medicine, a Guangzhou-based gene editing therapy company, has reportedly secured hundreds of millions of...
Zai Lab Partners with MediLink Therapeutics to Develop YL212 DLL3 ADC
Zai Lab Limited (NASDAQ: ZLAB, HKG: 9688), a China-based biopharmaceutical company, has announced a strategic...
OBiO Technology and ImmVira Partner on Oncolytic Virus Project for BLA Filing and Commercialization
OBiO Technology (Shanghai) Co., Ltd (SHA: 688238), a leading gene therapy specialist based in China,...
Dizal Pharma Plans to Raise $376.1 Million for Drug R&D and Industrialization
Dizal (Jiangsu) Pharmaceutical Co., Ltd (SHA: 688192), the China-based joint venture established by AstraZeneca (AZ,...
Shanghai Fosun Pharmaceutical Reported to Halt Sale of Stake in Gland Pharma
Indian media sources, including ET Now, have reported that Shanghai Fosun Pharmaceutical Group Co., Ltd...
LaNova Medicines and LegoChem Biosciences Partner to Develop Innovative ADC Product
Shanghai-based cancer therapy developer LaNova Medicines Ltd has entered into a research partnership agreement with...
Sunshine Guojian Pharmaceutical and Shenyang 3SBio Secure Exclusive Licensing Agreement for Antitumor Programs
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, a subsidiary of 3SBio Inc. (HKG: 1530), has announced...
Ping An Healthcare and Technology Partners with Chugai Pharmaceutical to Establish Angina Pectoris Center
Ping An Healthcare and Technology Co., Ltd (HKG: 1833), also recognized as PingAn Good Doctor,...
Tot Biopharmaceutical and Shanghai Escugen Partner on ADC Development and Commercialization
China-based Tot Biopharmaceutical International Co., Ltd (HKG: 1875) has announced a strategic partnership with Shanghai...
Meilitech Secures Series A+ Funding Led by Autobio Diagnostics for Cancer Detection Tech
Shenzhen-based nanopore early cancer detection product developer, Meilitech Co., has reportedly raised tens of millions...
Sable Therapeutics and Liuqiang Medical Ink Licensing Deal for Aesthetic Fat Reduction Patch
US-based Sable Therapeutics has announced plans to sign a licensing agreement with China-based Liuqiang Medical...
Beijing-Based Holox Secures Tens of Millions in Series A+ Financing for Healthcare Software
Holox, a Beijing-based developer of healthcare management software, has reportedly secured tens of millions of...